• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

    1.205 +0.005 (+0.42%)
    Streaming Delayed Price Updated: 4:15 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,040
    Open 1.205
    Bid (Size) 1.270 (400)
    Ask (Size) 1.370 (200)
    Prev. Close 1.200
    Today's Range 1.205 - 1.205
    52wk Range 1.200 - 10.99
    Shares Outstanding 114,010,448
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Friday's session. ↗
    Via Chartmill

    Performance

    YTD
    -83.2%
    -83.2%
    1 Month
    -41.5%
    -41.5%
    3 Month
    -87.7%
    -87.7%
    6 Month
    -78.4%
    -78.4%
    1 Year
    -81.0%
    -81.0%

    More News

    Read More
    Which stocks are moving before the opening bell on Friday? ↗
    Via Chartmill
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
    From Pomerantz LLP
    Via GlobeNewswire
    Karyopharm Therapeutics Inc (NASDAQ:KPTI) Posts Q1 Beat and Highlights ASCO Presentation, Shares Surge 7% ↗
    Via Chartmill
    Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market ↗
    Via Chartmill
    News headline image
    Karyopharm (KPTI) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Karyopharm Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript ↗
    Via Benzinga
    Topics Earnings
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI
    From Pomerantz LLP
    Via GlobeNewswire
    Top movers in Friday's session ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    Gapping stocks in Friday's session ↗
    Via Chartmill
    Friday's pre-market session: top gainers and losers ↗
    Via Chartmill
    Thursday's after hours session: top gainers and losers ↗
    Via Chartmill
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readouts ↗
    Via MarketBeat
    News headline image
    Karyopharm Therapeutics Teases ASCO SENTRY Data as FDA Path Comes Into Focus ↗
    Via MarketBeat
    News headline image
    Karyopharm (KPTI) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Karyopharm Therapeutics Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Karyopharm (KPTI) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Karyopharm (KPTI) Q1 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Registration Momentum Builds Across the Oncology Pipeline
    From USA News Group
    Via GlobeNewswire
    News headline image
    Karyopharm (KPTI) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Derivatives Earnings

    Frequently Asked Questions

    Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
    Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
    Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
    The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
    What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
    The current price of Karyopharm Therapeutics Inc. - Common Stock is 1.205
    When was Karyopharm Therapeutics Inc. - Common Stock last traded?
    The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 09/29/26 04:15 PM ET
    What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
    The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 137.38M
    How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
    Karyopharm Therapeutics Inc. - Common Stock has 137M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.